PAR · ALMKT.PA
Mauna Kea Technologies S.A.
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
Loading market information…
PAR · ALSGD.PA · EUR
Stock price, earnings
Quote as of Oct 29, 2026, 04:25 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
SpineGuard S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
SpineGuard S.A.’s next earnings report is currently expected on Apr 15, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SpineGuard S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SpineGuard S.A. specializes in the global design, development, and commercialization of advanced medical instruments for surgical procedures. Their product line includes various PediGuard probes: the Straight probe for precise screw placement; the Curved probe, featuring a tapered tip to facilitate easier pedicle penetration; and the Cannulated probe, engineered to help surgeons minimize radiation exposure during minimally-invasive operations. They also offer the PediGuard Threaded Device, a specialized drilling tool. Complementing these devices, SpineGuard provides the DSG (Dynamic Surgical Guidance) Connect app, which collects and visualizes real-time signals from DSG-enabled instruments during pedicle drilling, alongside the DSG smart screw for streamlined one-step screw insertion. SpineGuard's innovative solutions serve a broad spectrum of healthcare stakeholders, including patients, surgeons, operating room staff, and other healthcare providers. Founded in 2009, the company is headquartered in Vincennes, France.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€0.10-€0.00 (-0.31%)
Mauna Kea Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 58.36% below the high.
€5.55+€0.05 (+0.91%)
Euromedis Groupe’s quoted price sits in the upper half of its reported 52-week range, 9.76% below the high.
€0.85+€0.01 (+1.19%)
Biosynex S.A.’s quoted price sits in the lower half of its reported 52-week range, 45.86% below the high.
€0.14+€0.02 (+16.5%)
TME Pharma N.V.’s quoted price sits in the upper half of its reported 52-week range, 19.93% below the high.
€0.10-€0.00 (-2.44%)
AMA Corporation Plc’s quoted price sits in the lower half of its reported 52-week range, 50.98% below the high.
€2.20€0.00 (0.0%)
Media Lab S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 45.0% below the high.
€3.74-€0.20 (-5.08%)
Plant Advanced Technologies S.A.’s quoted price sits in the lower half of its reported 52-week range, 57.79% below the high.
€0.85-€0.07 (-7.61%)
Predilife S.A.’s quoted price sits in the lower half of its reported 52-week range, 78.75% below the high.
